TLR2 agonists and their structure-activity relationships

被引：0
|
作者：
Lu, Benjamin L. [1 ,2 ,3 ]
Williams, Geoffrey M. [1 ,2 ,3 ]
Brimble, Margaret A. [1 ,2 ,3 ]
机构：
[1] School of Biological Sciences, University of Auckland, 3A Symonds St, Auckland,1010, New Zealand
[2] School of Chemical Sciences, University of Auckland, 23 Symonds St, Auckland,1010, New Zealand
[3] Maurice Wilkins Centre for Molecular Biodiscovery, University of Auckland, Private Bag 92019, Auckland,1010, New Zealand
来源：
Organic and Biomolecular Chemistry | 2020年 / 18卷 / 27期
关键词：
Machinery;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：5073 / 5094
相关论文
共 50 条
  • [31] Structure-Activity Relationships and Quantitative Structure-Activity Relationships for Breast Cancer Resistance Protein (ABCG2)
    Gandhi, Yash A.
    Morris, Marilyn E.
    AAPS JOURNAL, 2009, 11 (03): : 541 - 552
  • [32] Structure-activity relationships of inverse agonists for G-protein-coupled receptors
    Soudijn, W
    van Wijngaarden, I
    Ijzerman, AP
    MEDICINAL RESEARCH REVIEWS, 2005, 25 (04) : 398 - 426
  • [33] Structure-Activity Relationships for Side Chain Oxysterol Agonists of the Hedgehog Signaling Pathway
    Corman, Audrey
    DeBerardinis, Albert M.
    Hadden, M. Kyle
    ACS MEDICINAL CHEMISTRY LETTERS, 2012, 3 (10): : 828 - 833
  • [34] Structure-activity relationships of GPR40 agonists based on a docking simulation
    Takeuchi, Masato
    Sun, Qi
    Hara, Takahumi
    Hirasawa, Akira
    Ishiguro, Masaji
    Suzuki, Takayoshi
    Miyata, Naoki
    Tsujimoto, Gozoh
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2011, 115 : 229P - 229P
  • [35] Structure-activity relationships and hepatic safety risks of thiazole agonists of the thrombopoietin receptor
    Antipas, Amy S.
    Blumberg, Laura C.
    Brissette, William H.
    Brown, Matthew F.
    Casavant, Jeffrey M.
    Doty, Jonathan L.
    Driscoll, James
    Harris, Thomas M.
    Jones, Christopher S.
    McCurdy, Sandra P.
    McElroy, Eric
    Mitton-Fry, Mark
    Munchhof, Michael J.
    Reim, David A.
    Reiter, Lawrence A.
    Ripp, Sharon L.
    Shavnya, Andrei
    Smeets, Marc I.
    Trevena, Kristen A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (14) : 4069 - 4072
  • [36] Discovery and Structure-Activity Relationships of the Neoseptins: A New Class of Toll-like Receptor-4 (TLR4) Agonists
    Morin, Matthew D.
    Wang, Ying
    Jones, Brian T.
    Su, Lijing
    Surakattula, Murali M. R. P.
    Berger, Michael
    Huang, Hua
    Beutler, Elliot K.
    Zhang, Hong
    Beutler, Bruce
    Boger, Dale L.
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (10) : 4812 - 4830
  • [37] Design, synthesis, and structure-activity relationships of diindolylmethane derivatives as cannabinoid CB2 receptor agonists
    Mahardhika, Andhika B. B.
    Ressemann, Anastasiia
    Kremers, Sarah E. E.
    Castanheira, Mariana S. Gregorio S.
    Schoeder, Clara T. T.
    Mueller, Christa E. E.
    Pillaiyar, Thanigaimalai
    ARCHIV DER PHARMAZIE, 2023, 356 (03)
  • [38] TOLL LIKE RECEPTOR 2 (TLR2) AGONISTS AS A PROMISING TREATMENT OPTION FOR ACUTE LYMPHATIC LEUKEMIA (ALL) IN CHILDREN: PRELIMINARY RESULTS FOR TLR2/1 AND TLR2/6 AGONISTS IN PRE B-ALL
    Rolf, Nina
    Kariminia, Amina
    Reid, Gregor
    Corthals, Sophie
    Ivison, Sabine
    Schultz, Kirk
    PEDIATRIC BLOOD & CANCER, 2010, 54 (06) : 815 - 815
  • [39] Enhanced immunostimulatory activity of in silico discovered agonists of Toll-like receptor 2 (TLR2)
    Murgueitio, M. S.
    Ebner, S.
    Hoertnagl, P.
    Rakers, C.
    Bruckner, R.
    Henneke, P.
    Wolber, G.
    Santos-Sierra, S.
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2017, 1861 (11): : 2680 - 2689
  • [40] Differential Response of Gestational Tissues to TLR3 Viral Priming Prior to Exposure to Bacterial TLR2 and TLR2/6 Agonists
    Rasheed, Zahirrah B. M.
    Lee, Yun S.
    Kim, Sung H.
    Rai, Ranjit K.
    Ruano, Camino S. M.
    Anucha, Eberechi
    Sullivan, Mark H. F.
    MacIntyre, David A.
    Bennett, Phillip R.
    Sykes, Lynne
    FRONTIERS IN IMMUNOLOGY, 2020, 11
12345